MGLN
Income statement / Annual
Last year (2020), Magellan Health, Inc.'s total revenue was $4.58 B,
a decrease of 36.06% from the previous year.
In 2020, Magellan Health, Inc.'s net income was $4.05 M.
See Magellan Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
Operating Revenue |
$4.58 B |
$7.16 B |
$7.31 B |
$5.84 B |
$4.84 B |
$4.60 B |
$3.76 B |
$3.55 B |
$3.21 B |
$2.80 B |
Cost of Revenue |
$4.46 B
|
$6.93 B
|
$7.12 B
|
$5.57 B
|
$4.58 B
|
$4.42 B
|
$3.55 B
|
$3.31 B
|
$2.96 B
|
$2.02 B
|
Gross Profit |
$118.79 M
|
$229.29 M
|
$197.18 M
|
$271.02 M
|
$258.94 M
|
$178.38 M
|
$215.08 M
|
$238.19 M
|
$249.58 M
|
$782.64 M
|
Gross Profit Ratio |
0.03
|
0.03
|
0.03
|
0.05
|
0.05
|
0.04
|
0.06
|
0.07
|
0.08
|
0.28
|
Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$876.61 M
|
$822.39 M
|
$723.50 M
|
$619.55 M
|
$557.51 M
|
$529.63 M
|
Other Expenses |
$98.39 M
|
$131.51 M
|
$132.66 M
|
$115.71 M
|
-$770.57 M
|
-$719.55 M
|
-$632.43 M
|
-$547.55 M
|
-$497.02 M
|
$58.62 M
|
Operating Expenses |
$98.39 M
|
$131.51 M
|
$132.66 M
|
$115.71 M
|
$106.05 M
|
$102.84 M
|
$91.07 M
|
$71.99 M
|
$60.49 M
|
$588.26 M
|
Cost And Expenses |
$4.56 B
|
$7.06 B
|
$7.25 B
|
$5.68 B
|
$4.68 B
|
$4.52 B
|
$3.64 B
|
$3.38 B
|
$3.02 B
|
$2.61 B
|
Interest Income |
$4.05 M
|
$19.19 M
|
$14.07 M
|
$5.89 M
|
$2.82 M
|
$2.17 M
|
$1.30 M
|
$1.99 M
|
$2.02 M
|
$2.78 M
|
Interest Expense |
$30.87 M
|
$36.15 M
|
$35.40 M
|
$25.98 M
|
$10.19 M
|
$6.58 M
|
$7.39 M
|
$3.00 M
|
$2.25 M
|
$2.50 M
|
Depreciation & Amortization |
$118.75 M
|
$131.51 M
|
$132.66 M
|
$115.71 M
|
$106.05 M
|
$102.84 M
|
$91.07 M
|
$71.99 M
|
$60.49 M
|
$58.62 M
|
EBITDA |
$487.41 M |
$248.48 M |
$211.25 M |
$276.97 M |
$263.85 M |
$183.25 M |
$221.55 M |
$240.18 M |
$251.60 M |
$255.79 M |
EBITDA Ratio |
0.11
|
0.03
|
0.03
|
0.05
|
0.05
|
0.04
|
0.06
|
0.07
|
0.08
|
0.09
|
Operating Income Ratio |
0.08
|
0.02
|
0.01
|
0.03
|
0.03
|
0.02
|
0.03
|
0.05
|
0.06
|
0.07
|
Total Other Income/Expenses Net |
-$409.15 M
|
-$36.15 M
|
-$35.40 M
|
-$26.04 M
|
-$12.28 M
|
-$9.29 M
|
-$12.56 M
|
-$3.00 M
|
-$2.25 M
|
-$2.50 M
|
Income Before Tax |
-$40.49 M
|
$80.82 M
|
$43.19 M
|
$135.22 M
|
$145.52 M
|
$71.12 M
|
$117.92 M
|
$165.19 M
|
$188.87 M
|
$194.66 M
|
Income Before Tax Ratio |
-0.01
|
0.01
|
0.01
|
0.02
|
0.03
|
0.02
|
0.03
|
0.05
|
0.06
|
0.07
|
Income Tax Expense |
-$44.53 M
|
$24.92 M
|
$19.01 M
|
$25.08 M
|
$69.73 M
|
$42.41 M
|
$43.69 M
|
$39.92 M
|
$37.84 M
|
$65.04 M
|
Net Income |
$4.05 M
|
$55.90 M
|
$24.18 M
|
$110.14 M
|
$75.79 M
|
$28.71 M
|
$74.23 M
|
$125.26 M
|
$151.03 M
|
$129.62 M
|
Net Income Ratio |
0
|
0.01
|
0
|
0.02
|
0.02
|
0.01
|
0.02
|
0.04
|
0.05
|
0.05
|
EPS |
0.16 |
2.28 |
0.97 |
4.72 |
3.27 |
1.15 |
2.78 |
4.63 |
5.51 |
4.25 |
EPS Diluted |
0.16 |
2.28 |
0.97 |
4.51 |
3.14 |
1.11 |
2.71 |
4.53 |
5.42 |
4.17 |
Weighted Average Shares Out |
$25.78 M
|
$24.56 M
|
$25.04 M
|
$23.33 M
|
$23.18 M
|
$24.87 M
|
$26.69 M
|
$27.05 M
|
$27.39 M
|
$30.48 M
|
Weighted Average Shares Out Diluted |
$25.78 M
|
$24.56 M
|
$25.04 M
|
$24.44 M
|
$24.16 M
|
$25.88 M
|
$27.36 M
|
$27.68 M
|
$27.88 M
|
$31.06 M
|
Link |
|
|
|
|
|
|
|
|
|
|